You are here: Industry Insights > Drug development

News List

Simplifying AI Data Analysis for Scientists – as REPROCELL, IBM and STFC Hartree Centre Successfully Launch Pharmacology-AI Platform PharmaSources
June 05, 2023
On June 1,2023,REPROCELL announces the launch of a new commercial service, Pharmacology-AI.
ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti.RiGHT - A Shortcut to Successful Lentivirus Manufacturing PharmaSources
May 18, 2023
May 17, 2023，ProBioGen announced the launch of their lentivirus (LV) packaging cell line Lenti.RiGHT as a new platinum standard for LV production at this year's PEGS Boston 2023.
SeraNovo and AstraZeneca to Collaborate on Research Projects PharmaSources
May 16, 2023
SeraNovo is pleased to announce the closing of a multi-compound deal with AstraZeneca.SeraNovo (Leiden, The Netherlands) is pleased to announce the closing of a multi-compound deal with AstraZeneca.
China launches project to promote use of AI in scitech research www.gov.cn
March 28, 2023
China has started the deployment of Artificial Intelligence for Science, a project to promote the use of AI in frontier sci-tech research.
Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards PharmaSources
March 16, 2023
Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumables.
CytoReason and Pfizer Extend Collaboration to Leverage Machine Learning in Drug Development AmericanPharmaceuticalReview
February 15, 2022
CytoReason announced the extension of its collaboration agreement with Pfizer.
6th China-ASEAN Summit for Drug Development and Cooperation opens in Guangxi NMPA
September 22, 2021
Co-sponsored by China's National Medical Products Administration (NMPA) and the government of the Guangxi Zhuang autonomous region, the Sixth China-ASEAN Summit...
CPhI Webinar: Trends and Advances in Patient Centric Drug Development - Watch On Demand cphi-online
June 24, 2021
Catch up on the latest trends and developments in patient centric drug development
Syneos Expands Decentralized Trial Capabilities contractpharma
June 23, 2021
Syneos Health expanded its Decentralized Clinical Trial capabilities to include a dedicated Decentralized Clinical Trials Site Advocacy Group, as part of its continuing efforts to move clinical trials closer to the patient.
New research could allow bioproduction of toxic compounds europeanpharmaceuticalreview
April 27, 2021
A paper shows implementing riboregulated switchable feedback promoters enables cells to produce the precursors for potentially toxic chemotherapeutic and anti-malarial drugs.

Previous page 1 2 3 4 5 6 Next page